Skip to main content
OpenTrials
Completed

NCT Number: NCT04251013

Multicenter RCT for BIliary Brushing: RX Cytology, BOSTON vs. Infinity®, US Endoscopy

The aim of this prospective national multicenter randomized study is to compare, during an ERCP for VBP stenosis, the sensitivity of two biliary brushes: the INFINITY® vs the RX Cytology Brush® The main objective is the comparison of the rates of positive diagnosis of biliary brushing in cases of adenocarcinoma stenosis The total number of subjects required: 50 (25 patients per group) Duration of the inclusion period: 2 years Duration of participation for each subject: from 7 days to 12 months (in case of negative initial withdrawal) Total duration of the study: 3 years

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Clinique Paris Bercy

Charenton-le-Pont, F-94220, France

About this study

The aim of this study is to compare, during an ERCP for VBP stenosis, the sensitivity of two biliary brushes: the INFINITY® vs the RX Cytology Brush®

OBJECTIVES

  • Main objective: Comparison of the rates of positive diagnosis of biliary brushing in cases of adenocarcinoma stenosis
  • Secondary objective (s):
  • Comparison of the quantification of the cellular material obtained (acellular, weak, or abundant), and the presence of cellular cupboards unhooked by the brush
  • Comparison of the 2 brushes false negative rates, and negative predictive value for the diagnosis of adenocarcinoma
  • Evaluation of the variation in the profitability of brushing and other sampling techniques (intra-biliary biopsies, puncture, aspiration of bile) according to the presence of a tumor mass syndrome of more than 1 cm.
  • Evaluation of the variation in the profitability of brushing and other sampling techniques (intra-biliary biopsies, puncture, aspiration of bile) according to the site of the stenosis (distal vs proximal BPV: common bile duct or intrahepatic duct), with the cost effectiveness
  • Technical failure rate of brushing and other samples (intra-biliary biopsies, bile aspiration)

This study concerns adult subjects with stenosis of the main bile duct (common bile duct or common hepatic duct).

ENDOSCOPIC PROCEDURE

  • Deep catheterization of the biliary duct (whatever the access technique: by the papilla or by precut) and cross stenosis by the guide wire, then biliary dilation (6 to 8mm)
  • Randomization if the inclusion criteria are met
  • Biliary brushing successively with the 2 brushes in the order designated by randomization:
  • Performing a dozen back and forth movements in the stenosis
  • Aspiration, if possible of bile by the catheter of the brush for cytological analysis
  • The contents of the brush will be spread over 3 blades (numbered) then sectioned and placed in cytolit with the contents of the tubing of the brush flushed with a few cc of cytolit. Each brush in a numbered pot. Blades 1,2 and 3 +/- bile 1 joined to pot n ° 1; blades 4,5 and 6 +/- bile 2 joined to pot 2
  • In the event of technical failure (impossibility of accessing the stenosis with the first or second brush, impossibility of removing the brush), the patient will be considered to have failed for this brush (absence of pathological material brought back)

All possible sampling methods will also be taken to obtain the anatomopathological diagnosis: intra-biliary biopsies with adult or pediatric forceps, wire-guided or not, biopsy samples guided by choledochoscopy, puncture under endo-ultrasonography, bile aspiration after release of the biliary stent, according to the physician's habits.

EFFECTIVE The total number of subjects required: 50 (25 patients per group) Duration of the inclusion period: 2 years Duration of participation for each subject: from 7 days to 12 months (in case of negative initial withdrawal) Total duration of the study: 3 years

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient admitted to one of the ERCP investigation centers with brushing and drainage for VBP stenosis (proximal or distal) during the study period
  • Patient whose age is greater than or equal to 18 years and less than 90 years
  • Patient ASA 1, ASA 2, ASA 3
  • Lack of participation in another clinical study
  • Signed informed consent

Exclusion criteria

  • Patients admitted for ERCP for jaundice by lithiasic obstruction
  • Patient under 18 or over 90
  • Patient ASA 4, ASA 5
  • Pregnant woman
  • Patient (s) with coagulation abnormalities preventing puncture: TP <50%, Platelets <50,000 / mm3, effective anti-coagulation in progress, clopidogrel in progress
  • Surgical setup (Billroth II, Roux en Y) preventing endoscopic access to the papilla
  • Patient unable to give personal consent
  • Lack of signed informed consent

Treatment and study plan

Biliary brushing with the RX Cytology brush, Boston Scientific

Device

Biliary brushing during ERCP:

  • Performing a dozen back and forth movements in the stenosis
  • Bile aspiration if possible, by the catheter of the brush for cytological analysis
  • The contents of the brush will be spread over 3 blades (numbered) then sectioned and placed in cytolit with the contents of the tubing of the brush flushed with a few cc of cytolit. Each brush in a numbered pot. Blades 1,2 and 3 +/- bile 1 joined to pot n ° 1; blades 4,5 and 6 +/- bile 2 joined to pot 2
  • In the event of technical failure (impossibility of accessing the stenosis with the first or second brush, impossibility of removing the brush), the patient will be considered to have failed for this brush (absence of pathological material brought back)

Biliary brushing with the Infinity® brush, US Endoscopy

Device

Biliary brushing during ERCP:

  • Performing a dozen back and forth movements in the stenosis
  • Bile aspiration if possible, by the catheter of the brush for cytological analysis
  • The contents of the brush will be spread over 3 blades (numbered) then sectioned and placed in cytolit with the contents of the tubing of the brush flushed with a few cc of cytolit. Each brush in a numbered pot. Blades 1,2 and 3 +/- bile 1 joined to pot n ° 1; blades 4,5 and 6 +/- bile 2 joined to pot 2
  • In the event of technical failure (impossibility of accessing the stenosis with the first or second brush, impossibility of removing the brush), the patient will be considered to have failed for this brush (absence of pathological material brought back)

Primary outcomes

  1. Sensibility for adenocarcinoma

    Time frame: 8 days to 1 year (if negative)

    Rate of positive diagnosis of biliary brushing in case of cholangiocarcinoma stenosis

Secondary outcomes

  1. Sample abundance

    Time frame: 8 days

    Quantification of the cellular material obtained (acellular, weak, or abundant), presence of cellular cupboards unhooked by the brush or average number of cells per field

  2. False negative

    Time frame: 1 year

    Negative brushing for a final diagnosis of cholangiocarcinoma

  3. Predictive Negative Value

    Time frame: 1 year

    probability that patients with a negative brushing truly don't have cholangiocarcinoma

  4. Feasibility of the 2 brushes: Analog visual scale

    Time frame: 1 day

    Analog visual scale: Feasibility scale (0 to 10, 0 for Extremely difficult to perform and 10 for very easy to perform)

  5. Feasibility of the intra-biliary biopsies: Analog visual scale

    Time frame: 1 day

    Analog visual scale: Feasibility scale (0 to 10, 0 for Extremely difficult to perform and 10 for very easy to perform)

  6. Feasibility of bile aspiration: Analog visual scale

    Time frame: 1 day

    Analog visual scale: Feasibility scale (0 to 10, 0 for Extremely difficult to perform and 10 for very easy to perform)

  7. Feasibility of stenosis puncture under ultrasonography: Analog visual scale

    Time frame: 1 day

    Analog visual scale: Feasibility scale (0 to 10, 0 for Extremely difficult to perform and 10 for very easy to perform)

Sponsors and collaborators

Lead sponsor

Société Française d'Endoscopie Digestive

Other

Registry information

Official study title

Multicenter RCT Comparing Two Brushes of Different Diameters for Biliary Stenosis: RX Cytology Brush, BOSTON vs. Infinity® Brush, US Endoscopy. BIB Study (BIliary Brushing)

Acronym: BIB

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Jan 31, 2020
Registry last updated
Jun 21, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.